The efficacy of topical anti-fungal agents to vitiligo

he investigation of possible efficacy of topical anti-fungal agents to autoimmune vitiligo - he investigation of possible efficacy of topical anti-fungal agents to autoimmune vitiligo

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs041180183

Enrollment

Registered

2019-03-29

Start date

2018-03-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune vitiligo

Interventions

apply topical anti-fungal agents to vitiligo lesion once or twice a day, its amount is equivalent to 0.1g to both palms lesion.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with vitiligo and concomitant seborrheic dermatitis or cutaneous fungal infection

Exclusion criteria

Exclusion criteria: patients who did not agree to be registered in this project

Design outcomes

Primary

Measure	Time frame
Re-pigmentation in vitiligo lesion	—

Contacts

Public ContactTamio Suzuki

Yamagata University Faculty of Medicine

tamsuz@med.id.yamagata-u.ac.jp+81-23-628-5361

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026